Minimal Optimal Dose of Sugammadex in Elective Surgery

Erasme University Hospital1 个研究点分布在 1 个国家目标入组 40 人开始时间: 2018年4月3日最近更新: 2019年2月15日

适应症

干预措施

试验速览

阶段: 4 期
状态: 已完成
发起方
入组人数: 40
试验地点: 1
主要终点: Evaluate the recovery time of the ratio 0.9.

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Time of appearance of TOF Ratio >0,9 with different doses of Sugammadex

详细描述

Design: monocentric, prospective, controlled, randomized, double-blind study Inclusion criteria: women and men> 18 years old, elective surgery, BMI <30, patients giving consent to free and informed participation in writing;

Exclusion criteria:

minor patients;
Patients refusing to sign the consent;
Patients included in another protocol within 3 months;
Pregnant or lactating patients;
Patients with a history of allergy to Sugammadex;
Patients with known neuromuscular disease;
Patients with renal or hepatic impairment.

Course of the study :

40 patients will be recruited at the time of the anesthesia consultation and randomized to double blind in 8 groups (the day before surgery)
All patients will benefit from general anesthesia. Anesthetic management

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Double (Participant, Care Provider)

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

•women and men> 18 years of age Elective Surgery BMI <30, patients who gave consent to free and informed participation in writing

排除标准

•minor patients;
•patients refusing to sign consent;
•patients included in another protocol within 3 months;
•pregnant or nursing patients;
•patients with a history of allergy to Sugammadex;
•patients with known neuromuscular disease
•patients with renal or hepatic impairment.